{"id":"https://openalex.org/W2074904551","doi":"https://doi.org/10.2174/138945011798829348","title":"HGF/c-MET Targeted Therapeutics: Novel Strategies for Cancer Medicine","display_name":"HGF/c-MET Targeted Therapeutics: Novel Strategies for Cancer Medicine","publication_year":2011,"publication_date":"2011-12-01","ids":{"openalex":"https://openalex.org/W2074904551","doi":"https://doi.org/10.2174/138945011798829348","mag":"2074904551","pmid":"https://pubmed.ncbi.nlm.nih.gov/21777195"},"language":"en","primary_location":{"id":"doi:10.2174/138945011798829348","doi":"https://doi.org/10.2174/138945011798829348","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138945011798829348","pdf_url":null,"source":{"id":"https://openalex.org/S140884253","display_name":"Current Drug Targets","issn_l":"1389-4501","issn":["1389-4501","1873-5592"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068368047","display_name":"Timothy Anthony Yap","orcid":"https://orcid.org/0000-0002-2154-3309","observed_orcids":["https://orcid.org/0000-0002-2154-3309"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Timothy A. Yap","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust and The Institute of Cancer Research Downs Road, Sutton, Surrey, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust and The Institute of Cancer Research Downs Road, Sutton, Surrey, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064026461","display_name":"Shahneen Kaur Sandhu","orcid":"https://orcid.org/0000-0002-8660-4475","observed_orcids":["https://orcid.org/0000-0002-8660-4475"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Shahneen K. Sandhu","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112030905","display_name":"Salma Moona Alam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Salma M. Alam","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Johann S. de Bono","raw_affiliation_strings":["Drug Development Unit and Division of Clinical Sciences, Royal Marsden NHS Foundation Trust and The Institute of Cancer Research Downs Road, Sutton, Surrey SM2 5PT, United Kingdom.,United Kingdom","Royal Marsden NHS Foundation Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit and Division of Clinical Sciences, Royal Marsden NHS Foundation Trust and The Institute of Cancer Research Downs Road, Sutton, Surrey SM2 5PT, United Kingdom.,United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]},{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust","institution_ids":["https://openalex.org/I1325846038"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.1409,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.91051995,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"12","issue":"14","first_page":"2045","last_page":"2058"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.5317000150680542,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.5317000150680542,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.39160001277923584,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.03229999914765358,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hgf-c-met-signaling","display_name":"HGF/MET signaling","score":0.9049999713897705},{"id":"https://openalex.org/keywords/c-met","display_name":"c-Met","score":0.8289999961853027},{"id":"https://openalex.org/keywords/hepatocyte-growth-factor","display_name":"hepatocyte growth factor","score":0.9570000171661377},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinases","display_name":"receptor tyrosine kinase","score":0.9089999794960022},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.5770000219345093},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.8169999718666077},{"id":"https://openalex.org/keywords/tumor-selectivity","display_name":"tumor selectivity","score":0.718999981880188},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.7200000286102295},{"id":"https://openalex.org/keywords/cell-proliferation-and-invasion","display_name":"cell proliferation and invasion","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C2776996007","wikidata":"https://www.wikidata.org/wiki/Q2399112","display_name":"Hepatocyte growth factor","level":3,"score":0.8913135528564453},{"id":"https://openalex.org/C2780467284","wikidata":"https://www.wikidata.org/wiki/Q5005897","display_name":"C-Met","level":4,"score":0.8376071453094482},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6943569183349609},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5998198390007019},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5275839567184448},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5257725715637207},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.517481803894043},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.5061294436454773},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4875049293041229},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.47713351249694824},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.44382593035697937},{"id":"https://openalex.org/C76419328","wikidata":"https://www.wikidata.org/wiki/Q74419","display_name":"Epithelial\u2013mesenchymal transition","level":4,"score":0.4303862750530243},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3803942799568176},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.3709675073623657},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.23171910643577576},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2072020173072815},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.17362526059150696}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017228","descriptor_name":"Hepatocyte Growth Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017228","descriptor_name":"Hepatocyte Growth Factor","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D019859","descriptor_name":"Proto-Oncogene Proteins c-met","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019859","descriptor_name":"Proto-Oncogene Proteins c-met","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/138945011798829348","doi":"https://doi.org/10.2174/138945011798829348","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138945011798829348","pdf_url":null,"source":{"id":"https://openalex.org/S140884253","display_name":"Current Drug Targets","issn_l":"1389-4501","issn":["1389-4501","1873-5592"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets","raw_type":"journal-article"},{"id":"pmid:21777195","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21777195","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug targets","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2391185526","https://openalex.org/W2793669837","https://openalex.org/W4322397550","https://openalex.org/W1992031126","https://openalex.org/W2117750856","https://openalex.org/W3171106033","https://openalex.org/W2811488921","https://openalex.org/W2036877832","https://openalex.org/W1985562847","https://openalex.org/W2264249081"],"abstract_inverted_index":{"The":[0,78],"hepatocyte":[1],"growth":[2],"factor/mesenchymal-epithelial":[3],"transition":[4],"factor":[5],"(HGF/c-MET)":[6],"receptor":[7],"tyrosine":[8],"kinase":[9],"(RTK)":[10],"pathway":[11],"plays":[12],"a":[13,43,104],"pleotropic":[14],"role":[15,80,129],"in":[16,30,42,63,68,84,95,100,120,134,150],"cell":[17],"proliferation,":[18],"migration,":[19],"invasion,":[20],"angiogenesis":[21],"and":[22,33,58,65,98,142],"survival.":[23],"Although":[24],"it":[25],"has":[26,60],"critical":[27],"physiological":[28],"functions":[29],"embryonic":[31],"development":[32],"tissue":[34,97],"repair,":[35],"this":[36],"signaling":[37,94,133],"cascade":[38],"is":[39,66],"frequently":[40],"deregulated":[41],"wide":[44],"range":[45],"of":[46,71,81,106,130],"tumors.":[47],"Aberrant":[48],"HGF/c-MET":[49,93,132,152],"signaling,":[50],"driven":[51],"by":[52],"various":[53],"mechanisms,":[54],"including":[55],"constitutive":[56],"activation":[57],"over-expression,":[59],"multifunctional":[61],"effects":[62],"oncogenesis":[64],"implicated":[67],"the":[69,126,146],"acquisition":[70],"an":[72,117],"aggressive":[73],"phenotype":[74],"with":[75],"metastatic":[76],"potential.":[77],"central":[79],"c-MET":[82,115],"activity":[83],"cancer":[85],"progression,":[86,136],"as":[87,89,137,139],"well":[88,138],"disparities":[90],"between":[91],"quiescent":[92],"normal":[96],"overexpression":[99],"tumor":[101,107],"may":[102],"provide":[103],"degree":[105],"selectivity":[108],"for":[109],"therapeutic":[110],"intervention,":[111],"making":[112],"HGF":[113],"or":[114],"inhibition":[116],"attractive":[118],"proposition":[119],"oncology.":[121],"This":[122],"review":[123],"focuses":[124],"on":[125,145],"underlying":[127],"oncogenic":[128],"aberrant":[131],"malignant":[135],"recent":[140],"preclinical":[141],"clinical":[143],"data":[144],"different":[147],"strategies":[148],"employed":[149],"inhibiting":[151],"function.":[153]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}